pyruvic acid has been researched along with Bright Disease in 1 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roointan, A | 1 |
| Ghaeidamini, M | 1 |
| Shafieizadegan, S | 1 |
| Hudkins, KL | 1 |
| Gholaminejad, A | 1 |
1 review available for pyruvic acid and Bright Disease
| Article | Year |
|---|---|
Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies.
Topics: Biomarkers; Choline; Glomerulonephritis; Humans; Leucine; Metabolome; Metabolomics; Pyruvic Acid | 2023 |